155 related articles for article (PubMed ID: 9622203)
21. Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist.
Lyden PD; Lonzo L
Stroke; 1994 Jan; 25(1):189-96. PubMed ID: 7903492
[TBL] [Abstract][Full Text] [Related]
22. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Buchan AM; Slivka A; Xue D
Brain Res; 1992 Mar; 574(1-2):171-7. PubMed ID: 1386274
[TBL] [Abstract][Full Text] [Related]
23. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.
Bordi F; Pietra C; Ziviani L; Reggiani A
Exp Neurol; 1997 Jun; 145(2 Pt 1):425-33. PubMed ID: 9217078
[TBL] [Abstract][Full Text] [Related]
24. Ability of NMDA and non-NMDA receptor antagonists to inhibit cerebral ischemic damage in aged rats.
Suzuki Y; Takagi Y; Nakamura R; Hashimoto K; Umemura K
Brain Res; 2003 Feb; 964(1):116-20. PubMed ID: 12573519
[TBL] [Abstract][Full Text] [Related]
25. Mild hypothermia and MK-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model.
Frazzini VI; Winfree CJ; Choudhri HF; Prestigiacomo CJ; Solomon RA
Neurosurgery; 1994 Jun; 34(6):1040-5; discussion 1045-6. PubMed ID: 7916129
[TBL] [Abstract][Full Text] [Related]
26. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.
Savitz SI; Erhardt JA; Anthony JV; Gupta G; Li X; Barone FC; Rosenbaum DM
J Cereb Blood Flow Metab; 2000 Aug; 20(8):1197-204. PubMed ID: 10950380
[TBL] [Abstract][Full Text] [Related]
27. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia.
Yam PS; Dunn LT; Graham DI; Dewar D; McCulloch J
J Cereb Blood Flow Metab; 2000 May; 20(5):772-9. PubMed ID: 10826527
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats.
Matucz E; Móricz K; Gigler G; Benedek A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2006 Dec; 1123(1):60-7. PubMed ID: 17064671
[TBL] [Abstract][Full Text] [Related]
29. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
30. Glutamate antagonist MK-801 attenuates incomplete but not complete infarction in thrombotic distal middle cerebral artery occlusion in Wistar rats.
Yao H; Markgraf CG; Dietrich WD; Prado R; Watson BD; Ginsberg MD
Brain Res; 1994 Apr; 642(1-2):117-22. PubMed ID: 7913391
[TBL] [Abstract][Full Text] [Related]
31. Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.
Hosomi N; Ban CR; Naya T; Takahashi T; Guo P; Song XY; Kohno M
J Cereb Blood Flow Metab; 2005 Aug; 25(8):959-67. PubMed ID: 15729288
[TBL] [Abstract][Full Text] [Related]
32. Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.
Zhu YM; Wang CC; Chen L; Qian LB; Ma LL; Yu J; Zhu MH; Wen CY; Yu LN; Yan M
Brain Res; 2013 Feb; 1494():1-8. PubMed ID: 23219579
[TBL] [Abstract][Full Text] [Related]
33. [Protective effect of dl-3-n-butylphthalide on ischemic neurological damage and abnormal behavior in rats subjected to focal ischemia].
Liu XG; Feng YP
Yao Xue Xue Bao; 1995 Dec; 30(12):896-903. PubMed ID: 8712015
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional response to circumscribed cortical brain ischemia: spatiotemporal patterns in ischemic vs. remote non-ischemic cortex.
Küry P; Schroeter M; Jander S
Eur J Neurosci; 2004 Apr; 19(7):1708-20. PubMed ID: 15078545
[TBL] [Abstract][Full Text] [Related]
35. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia.
Memezawa H; Zhao Q; Smith ML; Siesjö BK
Brain Res; 1995 Jan; 670(1):48-52. PubMed ID: 7719723
[TBL] [Abstract][Full Text] [Related]
37. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists.
Yamashita K; Vogel P; Fritze K; Back T; Hossmann KA; Wiessner C
Brain Res; 1996 Oct; 735(2):285-97. PubMed ID: 8911667
[TBL] [Abstract][Full Text] [Related]
39. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
40. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
Graham SH; Chen J; Lan JQ; Simon RP
J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
